Advertisement
Home Tags Cancer: Cervical

Tag: Cancer: Cervical

Perceived Financial Barriers Hinder Cervical Cancer Screening

72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening

Women’s Cancer Screenings Plummeted During Pandemic

Decline especially noticeable among women of racial and ethnic minority groups with low incomes

Many Older Women Not Eligible to Quit Cervical Cancer Screening

Findings consistent among women with employer-based insurance and those treated at a safety net health center

Lower Incomes Increase Cancer Worry, Anxiety During Pandemic

Worry, anxiety up with lower annual income for Medicaid-insured women receiving gynecologic oncology care during March 15 to April 15, 2020

Cervical Cancer Screening Rates Dropped During Stay-at-Home Order

Cervical cytology screening rates per 100 person-months decreased 78 percent among women aged 21 to 29 years

1 1/24 -- Men

Breast, Cervical, CRC Screening Below Healthy People 2020 Targets

Colorectal cancer test receipt near target in 2018, with 66.9 percent of adults aged 50 to 75 years up to date with testing

Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19

Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black

Women with invasive cervical cancer have an increased rate of iatrogenic and noniatrogenic injuries during diagnostic workup

Rate of Injuries Increased Around Diagnosis of Cervical Cancer

Rates of iatrogenic, noniatrogenic injuries higher for women having diagnostic workup for cervical cancer
Quadrivalent human papillomavirus vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer

HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk

Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
For gynecologic oncology patients with COVID-19

Most Gynecologic Cancer Therapy Not Tied to Higher COVID-19 Risk

Only recent immunotherapy use linked to death due to COVID-19 in gynecologic oncology patients